EcoDrugPlus

Thromboxane A2 Receptor

Ensembl ID : ENSLCRG00005023373
Gene Symbol: TBXA2R
3 Cross references
192 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSLCRG00005006200
Gene Symbol: TYMP
2 Cross references
172 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSLCRG00005022270
Gene Symbol: TYMS
3 Cross references
223 Possible Orthologues:

Thyroid Hormone Receptor Beta

Ensembl ID : ENSLCRG00005007879
Gene Symbol: THRB
3 Cross references
388 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSLCRG00005007874
Gene Symbol: TRHR
3 Cross references
201 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor B

Ensembl ID : ENSLCRG00005008507
Gene Symbol: TRHRB
3 Cross references
193 Possible Orthologues:

Tissue Factor

Ensembl ID : ENSLCRG00005018424
Gene Symbol: LOC104928194
2 Cross references
172 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSLCRG00005017579
Gene Symbol: TLR2
1 Cross references
183 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSLCRG00005010346
Gene Symbol: TLR7
3 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSLCRG00005010347
Gene Symbol: TLR8
1 Cross references
187 Possible Orthologues:

Toll-Like Receptor 2 Type-2

Ensembl ID : ENSLCRG00005000947
Gene Symbol: LOC104938453
3 Cross references
213 Possible Orthologues:

Trace Amine-Associated Receptor 1

Ensembl ID : ENSLCRG00005009877
Gene Symbol: LOC109140429
2 Cross references
392 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).